Loading...
•
Sep 30, 2024
Cencora Q4 2024 Earnings Report
Cencora reported a revenue increase of 14.7 percent, reaching $79.1 billion, and an adjusted diluted EPS of $3.34 for the fourth quarter.
Key Takeaways
Cencora's fiscal 2024 fourth quarter saw a significant revenue increase of 14.7% to $79.1 billion. GAAP diluted EPS was $0.02, while adjusted diluted EPS rose by 16.8% to $3.34. The company also announced an 8% increase in its quarterly dividend.
Revenue increased by 14.7% to $79.1 billion in the fourth quarter.
GAAP diluted EPS was $0.02 for the quarter.
Adjusted diluted EPS increased by 16.8% to $3.34 in the fiscal fourth quarter.
The company increased its quarterly dividend by 8 percent.
Cencora
Cencora
Forward Guidance
Cencora introduced its full fiscal year 2025 financial guidance, which reflects adjusted operating income growth of 5 percent to 6.5 percent and adjusted diluted EPS growth of 8 percent to 10 percent.
Positive Outlook
- Revenue growth to be in the range of 7 to 9 percent
- U.S. Healthcare Solutions segment revenue growth to be in the range of 7 to 9 percent
- International Healthcare Solutions segment revenue growth to be in the range of 7 to 9 percent
- Adjusted diluted earnings per share to be in the range of $14.80 to $15.10
- Adjusted operating income growth to be in the range of 5 to 6.5 percent
Challenges Ahead
- Interest expense to be in the range of $150 million to $170 million
- Adjusted effective tax rate of approximately 21 percent
- Adjusted free cash flow to be in the range of $2.0 billion to $3.0 billion
- Capital expenditures to be approximately $600 million
- Weighted average diluted shares outstanding to be approximately 196 million